Evidence map›Paper›PMID 27696217›Full record

ArticleCurrent topics in behavioral neurosciences2017

Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.

S Stevens Negus, Matthew L Banks

Open access · hybridAbstract read
In one paragraph

Article in Current topics in behavioral neurosciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Structure-Activity Relationship ofACS chemical neuroscience · 2023
    Article
  11. Article
  12. Neuropsychopharmacology of Emerging Drugs of Abuse:International journal of molecular sciences · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

S Stevens NegusDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA. sidney.negus@vcuhealth.org.
Matthew L BanksDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Virginia Commonwealth University · US

Funding

Synthetic cathinones: a new class of illicit drugs affecting DAT & SERTR01DA033930 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI ELTIT, JOSE MIGUEL, GLENNON, RICHARD A · 2012 to 2016
$2.7M
NIDA NIH HHS R01 DA033930
6 · The paper itself

Abstract

Many cathinone analogs act as substrates or inhibitors at dopamine, norepinephrine, and serotonin transporters (DAT, NET, SERT, respectively). Drug selectivity at DAT vs. SERT is a key determinant of abuse potential for monoamine transporter substrates and inhibitors, such that potency at DAT > SERT is associated with high abuse potential, whereas potency at DAT < SERT is associated with low abuse potential. Quantitative structure-activity relationship (QSAR) studies with a series of 4-substituted methcathinone analogs identified volume of the 4-position substituent on the methcathinone phenyl ring as one structural determinant of both DAT vs. SERT selectivity and abuse-related behavioral effects in an intracranial self-stimulation procedure in rats. Subsequent modeling studies implicated specific amino acids in DAT and SERT that might interact with 4-substituent volume to determine effects produced by this series of cathinone analogs. These studies illustrate use of QSAR analysis to investigate pharmacology of cathinones and function of monoamine transporters.

Indexed as

Substance-Related DisordersAmphetamineAnimalsBehavior, AnimalDopamine Plasma Membrane Transport ProteinsFenfluramineHumansMethamphetamineMethylaminesN-Methyl-3,4-methylenedioxyamphetamineNorepinephrine Plasma Membrane Transport ProteinsPropiophenonesPsychotropic DrugsQuantitative Structure-Activity RelationshipRatsSelf Administration4-fluoromethcathinone4-methoxymethcathinoneAmphetamineclephedroneDopamine Plasma Membrane Transport ProteinsFenfluraminemephedroneMethamphetamineMethylaminesmonomethylpropionN-Methyl-3,4-methylenedioxyamphetamineNorepinephrine Plasma Membrane Transport ProteinsPropiophenonesPsychotropic DrugsSerotonin Plasma Membrane Transport ProteinsDopamine transporterFlephedroneIntracranial self-stimulationMephedroneMethcathinoneMethedroneMicrodialysisSerotonin transporterStructure–activity relationship

Identifiers

PMID27696217
PMCPMC5425248
OpenAlexW2525309745

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.